Mitesh

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Estradot® 25micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 3rd April 2025, SSP082, provides that for every Estradot® 25micrograms/24hours patch originally prescribed either one Evorel® 25 patch or one Estraderm® MX [...]

The post SSP for Estradot® 25micrograms/24hours patch issued appeared first on Community Pharmacy England.

From 1 April 2025,  Progesterone micronised 200mg capsules (Gepretix®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the April 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to [...]

The post Progesterone micronised 200mg capsules (Gepretix®) added to the HRT PPC medicines list from April 2025 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (28/03/2025) announced the following list of price concessions for March 2025: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £6.39 Calcium and Ergocalciferol tablets [...]

The post March 2025 Price Concessions 3rd Update appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Roundup March 2025 has been published and includes articles on: Prolonged-release opioids: Removal of indication for relief of post-operative pain Suzhou Surgicare disposable Hysteroscopy Sheath – Recall due to withdrawn CE certificate. DSI/2025/001 Letters and Recalls in February and March 2025 News Roundup – [...]

The post MHRA Safety Roundup: March 2025 appeared first on Community Pharmacy England.